Literature DB >> 1737222

Prevention of blindness in giant cell arteritis by corticosteroid treatment.

A B Myles1, T Perera, M G Ridley.   

Abstract

Ninety-six patients with giant cell arteritis (GCA) seen from 1968 to 1985 were studied with regard to the starting dose of prednisolone and the development of serious ocular complications, which proved to be very few after treatment was started. Those starting on 20 mg of prednisolone or less daily fared at least as well as those starting on higher doses. Analysis of the literature does not support the belief that higher doses provide greater protection from blindness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737222     DOI: 10.1093/rheumatology/31.2.103

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  14 in total

Review 1.  Polymyalgia rheumatica/temporal arteritis: recent advances.

Authors:  Maria-Louise Barilla-LaBarca; Deborah J Lenschow; Richard D Brasington
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

2.  Giant Cell Arteritis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

3.  Giant cell arteritis.

Authors:  J C Mason; M J Walport
Journal:  BMJ       Date:  1992-07-11

4.  Polymyalgia rheumatica and giant cell arteritis.

Authors:  A B Myles
Journal:  BMJ       Date:  1995-11-04

5.  Successful treatment of ischaemic optic neuropathy secondary to giant cell arteritis with intravenous pulse of methylprednisolone.

Authors:  M M Costa; J C Romeu; P da Silva; V de Queiroz
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

6.  Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.

Authors:  M J Kupersmith; R Langer; H Mitnick; R Spiera; H Spiera; M Richmond; S Paget
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

7.  Plasma viscosity in giant cell arteritis as a predictor of disease activity.

Authors:  M Gudmundsson; E Nordborg; B A Bengtsson; A Bjelle
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 8.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

9.  Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients.

Authors:  J C Mertens; G Willemsen; J L Van Saase; J H Bolk; B A Dijkmans
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

10.  [Current patient care of giant cell arteritis in Rhineland-Palatinate].

Authors:  Christian von Kiel; Matthias Dreher; Konstantinos Triantafyllias; Peter Heinz; Andreas Schwarting
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.